{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:33:02Z","timestamp":1791977582367,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004685.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000}}],"reference-count":69,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004685.pub3","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T12:22:20Z","timestamp":1463055740000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Systemic antifungal therapy for tinea capitis in children"],"prefix":"10.1002","volume":"2016","author":[{"given":"Xiaomei","family":"Chen","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Dermatology & Venereology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Jiang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Dermatology & Venereology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Center of Geriatrics and Gerontology; No. 37, Guo Xue Lane Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urb\u00e0","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"CL\u013aNICA GO&FER; Unit of Dermatology; Riera Blanca 6-8, L\u00b4Hospitalet Barcelona Spain 08903"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufang","family":"Lin","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Center of Geriatrics and Gerontology; No. 37, Guo Xue Lane Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Hua","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Dermatology & Venereology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siliang","family":"Xue","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Dermatology & Venereology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Dermatology & Venereology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Bennett","sequence":"additional","affiliation":[{"name":"Coventry University; Centre for Technology Enabled Health Research (CTEHR); Priory Street Coventry UK CV1 5FB"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,5,12]]},"reference":[{"issue":"1 Pt 1","key":"10.1002\/14651858.CD004685.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0190-9622(00)90013-6","article-title":"Comparison of terbinafine and griseofulvin in the treatment of tinea capitis","volume":"42","author":"C\u00e1ceres-R\u00edos","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004685.pub3-BIB0002|cit2","first-page":"1s21","article-title":"Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. [Abstract 015]","volume":"125","author":"C\u00e1ceres-R\u00edos","year":"1998","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"1","key":"10.1002\/14651858.CD004685.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/09546630510025932","article-title":"Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole","volume":"16","author":"Dastghaib","year":"2005","journal-title":"Journal of Dermatological Treatment"},{"issue":"5","key":"10.1002\/14651858.CD004685.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11046-011-9438-2","article-title":"A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China","volume":"172","author":"Deng","year":"2011","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1002\/14651858.CD004685.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaad.2008.02.019","article-title":"Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials","volume":"59","author":"Elewski","year":"2008","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD004685.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jaad.2005.07.028","article-title":"A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis","volume":"53","author":"Foster","year":"2005","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD004685.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1542\/peds.109.4.602","article-title":"Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study","volume":"109","author":"Friedlander","year":"2002","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD004685.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2133.2001.04022.x","article-title":"A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis","volume":"144","author":"Fuller","year":"2001","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD004685.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00006454-198701000-00012","article-title":"Epidemiology and treatment of tinea capitis: ketoconazole vs. griseofulvin","volume":"6","author":"Gan","year":"1987","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"5","key":"10.1002\/14651858.CD004685.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1525-1470.2001.01978.x","article-title":"Therapeutic options for the treatment of tinea capitis caused by trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole","volume":"18","author":"Gupta","year":"2001","journal-title":"Pediatric Dermatology"},{"issue":"3","key":"10.1002\/14651858.CD004685.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1365-2133.1999.02713.x","article-title":"Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group","volume":"140","author":"Hamm","year":"1999","journal-title":"British Journal of Dermatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004685.pub3-BIB0012|cit12","first-page":"1s133","article-title":"What is the best approach to tinea capitis with terbinafine? [Abstract P147]","volume":"125","author":"Schwinn","year":"1998","journal-title":"Annales de Dermatologie et de Venereologie"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004685.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"s232","DOI":"10.1016\/S0926-9959(98)95441-1","article-title":"What is the best approach to tinea capitis with terbinafine? [Abstract P199]. The 7th Congress of the European Academy of Dermatology and Venereology; 7-11 Oct 1998; Nice","volume":"11","author":"Schwinn","year":"1998","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0014|cit14","first-page":"35","article-title":"A randomized, double blind trial of the efficacy and tolerability of terbinafine once daily compared to griseofulvin once daily in the treatment of tinea capitis","volume-title":"Royal Society of Medicine Services International Congress Series","volume":"205","author":"Alvi","year":"1992"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004685.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"s79","DOI":"10.1016\/0926-9959(95)96061-C","article-title":"Randomized double-blind multicentre study of efficacy and tolerability of terbinafine for 1, 2, and 4 weeks in the treatment of tinea capitis","volume":"5","author":"Haroon","year":"1995","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"3","key":"10.1002\/14651858.CD004685.pub3-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3109\/09546639509097176","article-title":"A randomized double-blind comparative study of terbinafine and griseofulvin in tinea capitis","volume":"6","author":"Haroon","year":"1995","journal-title":"Journal of Dermatological Treatment"},{"issue":"1","key":"10.1002\/14651858.CD004685.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2133.1996.tb03613.x","article-title":"A randomized double-blind comparative study of terbinafine for 1, 2, and 4 weeks in tinea capitis","volume":"135","author":"Haroon","year":"1996","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD004685.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-2133.1998.02465.x","article-title":"A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis","volume":"139","author":"Jahangir","year":"1998","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD004685.pub3-BIB0019|cit19","first-page":"281","article-title":"Efficacy of terbinafine vs. griseofulvin in tinea capitis in the northern areas of Pakistan","volume":"21","author":"Khan","year":"2011","journal-title":"Journal of Pakistan Association of Dermatologists"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD004685.pub3-BIB0020|cit20","first-page":"272-3. Comment","article-title":"Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis","volume":"37","author":"Kullavanijaya","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD004685.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2133.2002.04744.x","article-title":"A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species","volume":"146","author":"Lipozencic","year":"2002","journal-title":"British Journal of Dermatology"},{"issue":"10","key":"10.1002\/14651858.CD004685.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"743-7. Comment","DOI":"10.1111\/j.1365-4362.1994.tb01525.x","article-title":"Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children","volume":"33","author":"L\u00f3pez-G\u00f3mez","year":"1994","journal-title":"International Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD004685.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00006454-198801000-00009","article-title":"Double blind study of ketoconazole and griseofulvin in dermatophytoses","volume":"7","author":"Mart\u00ednez-Roig","year":"1988","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"3","key":"10.1002\/14651858.CD004685.pub3-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/09546639909056027","article-title":"Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis","volume":"10","author":"Memisoglu","year":"1999","journal-title":"Journal of Dermatological Treatment"},{"issue":"1060","key":"10.1002\/14651858.CD004685.pub3-BIB0025|cit25","first-page":"55","article-title":"Griseofulvin and terbinafine in the treatment of tinea capitis in children","volume":"111","author":"Rademaker","year":"1998","journal-title":"New Zealand Medical Journal"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD004685.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0190-9622(97)80141-7","article-title":"Fluconazole for the treatment of tinea capitis in children","volume":"37","author":"Solomon","year":"1997","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD004685.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1468-3083.1998.tb00767.x","article-title":"Efficacy, safety and tolerability of terbinafine for tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1, 2 and 4 weeks","volume":"11","author":"Filho","year":"1998","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"1","key":"10.1002\/14651858.CD004685.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00006565-198503000-00005","article-title":"Comparison of ketoconazole and griseofulvin for treatment of tinea capitis in childhood: a preliminary study","volume":"1","author":"Tanz","year":"1985","journal-title":"Pediatric Emergency Care"},{"issue":"6","key":"10.1002\/14651858.CD004685.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-3476(88)80232-4","article-title":"Treating tinea capitis: Should ketoconazole replace griseofulvin?","volume":"112","author":"Tanz","year":"1988","journal-title":"Journal of Pedriatics"},{"issue":"3","key":"10.1002\/14651858.CD004685.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2230.2004.01493.x","article-title":"Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine","volume":"29","author":"Ungpakorn","year":"2004","journal-title":"Clinical and Experimental Dermatology"},{"issue":"12","key":"10.1002\/14651858.CD004685.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/00006454-198712000-00003","article-title":"Randomized controlled trial of intralesional corticosteroid and griseofulvin vs. griseofulvin alone for treatment of kerion","volume":"6","author":"Ginsburg","year":"1987","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD004685.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1525-1470.1994.tb00079.x","article-title":"Treatment of kerions","volume":"11","author":"Honig","year":"1994","journal-title":"Pediatric Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD004685.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-280X.1999.00199.x","article-title":"A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone","volume":"37","author":"Hussain","year":"1999","journal-title":"Medical Mycology"},{"issue":"Suppl","key":"10.1002\/14651858.CD004685.pub3-BIB0034|cit34","first-page":"11","article-title":"Is itraconazole the treatment of choice in Microsporum canis tinea capitis?","volume":"31","author":"Koumantaki-Mathioudaki","year":"2005","journal-title":"Drugs Under Experimental & Clinical Research"},{"issue":"8","key":"10.1002\/14651858.CD004685.pub3-BIB0035|cit35","first-page":"737","article-title":"Treatment of tinea capitis - griseofulvin versus fluconazole - a comparative study","volume":"11","author":"Shemer","year":"2013","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft [Journal of the German Society of Dermatology]"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004685.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1365-2133.2006.07258_1.x","article-title":"A prospective, randomized, single-blinded trial to determine the efficacy of single and weekly dose regimens of oral griseofulvin versus 6 weeks of daily dosing in the treatment of tinea capitis in children. British Society for Paediatric Dermatology: Summaries of Papers [PA-6]","volume":"155","author":"Pather","year":"2006","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/01.inf.0000180577.29853.a0","article-title":"Pharmacokinetics of terbinafine in young children treated for tinea capitis","volume":"24","author":"Abdel-Rahman","year":"2005","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD004685.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00006454-199902000-00025","article-title":"Ecology, epidemiology and diagnosis of tinea capitis","volume":"18","author":"Aly","year":"1999","journal-title":"The Pediatric Infectious Diseases Journal"},{"issue":"9-10","key":"10.1002\/14651858.CD004685.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1439-0507.2004.01024.x","article-title":"Tinea capitis caused by Microsporum canis treated with terbinafine","volume":"47","author":"Aste","year":"2004","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0040|cit40","first-page":"89","article-title":"Management of tinea capitis in childhood","volume":"3","author":"Bennassar","year":"2010","journal-title":"Clinical, Cosmetic & Investigational Dermatology: CCID"},{"issue":"4","key":"10.1002\/14651858.CD004685.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1525-1470.2000.01784.x","article-title":"Oral griseofulvin remains the treatment of choice for tinea capitis in children","volume":"17","author":"Bennett","year":"2000","journal-title":"Pediatric Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD004685.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00006454-199902000-00027","article-title":"Pharmacologic basis for the treatment of tinea capitis","volume":"18","author":"Blumer","year":"1999","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0043|cit43","unstructured":"Bortolussi R Martin S Canadian Paediatric Society Antifungal agents for common outpatient paediatric infections http:\/\/www.cps.ca\/documents\/position\/antifungal-agents-common-infections"},{"issue":"2","key":"10.1002\/14651858.CD004685.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14656566.5.2.219","article-title":"Therapeutic options in the treatment of tinea capitis","volume":"5","author":"Chan","year":"2004","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"11","key":"10.1002\/14651858.CD004685.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.5694\/j.1326-5377.2003.tb05363.x","article-title":"Which drug is most effective in treating childhood tinea capitis caused by Microsporum species?","volume":"178","author":"Commens","year":"2003","journal-title":"The Medical Journal of Australia"},{"issue":"2","key":"10.1002\/14651858.CD004685.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1468-3083.2004.00854.x","article-title":"Efficacy and tolerability of 8 weeks' treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses","volume":"18","author":"Devliotou-Panagiotidou","year":"2004","journal-title":"Journal of the European Academy of Dermatology & Venereology"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD004685.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0190-9622(00)90001-X","article-title":"Tinea capitis: a current perspective","volume":"42","author":"Elewski","year":"2000","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD004685.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1542\/peds.2004-0428","article-title":"Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials","volume":"114","author":"Fleece","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD004685.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1525-1470.2000.01789.x","article-title":"The optimal therapy for tinea capitis","volume":"17","author":"Friedlander","year":"2000","journal-title":"Pediatric Dermatology"},{"issue":"7388","key":"10.1002\/14651858.CD004685.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/bmj.326.7388.539","article-title":"Diagnosis and management of scalp ringworm","volume":"326","author":"Fuller","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjd.13196","article-title":"British Association of Dermatologists' guidelines for the management of tinea capitis 2014","volume":"171","author":"Fuller","year":"2014","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004685.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1439-0507.2007.01424.x","article-title":"Epidemiology of tinea capitis in Europe: current state and changing patterns","volume":"50","author":"Ginter-Hanselmayer","year":"2007","journal-title":"Mycoses"},{"issue":"3","key":"10.1002\/14651858.CD004685.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1525-1470.1999.00050.x","article-title":"Tinea capitis: an overview with emphasis on management","volume":"16","author":"Gupta","year":"1999","journal-title":"Pediatric Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD004685.pub3-BIB0054|cit54","first-page":"369","article-title":"Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis","volume":"7","author":"Gupta","year":"2008","journal-title":"Journal of Drugs in Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD004685.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1525-1470.2012.01866.x","article-title":"Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis","volume":"30","author":"Gupta","year":"2013","journal-title":"Pediatric Dermatology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD004685.pub3-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","article-title":"Epidemiological trends in skin mycoses worldwide","volume":"51","author":"Havlickova","year":"2008","journal-title":"Mycoses"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0057|cit57","first-page":"online","article-title":"Chapter 37 Skin Diseases","volume-title":"Disease Control Priorities in Developing Countries.","author":"Hay","year":"2006"},{"issue":"1","key":"10.1002\/14651858.CD004685.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2133.2000.03530.x","article-title":"Guidelines for the management of tinea capitis","volume":"143","author":"Higgins","year":"2000","journal-title":"British Journal of Dermatology"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0059|cit59","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD004685.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1525-1470.2010.01137.x","article-title":"Guidelines for the management of tinea capitis in children","volume":"27","author":"Kakourou","year":"2010","journal-title":"Pediatric Dermatology"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0061|cit61","first-page":"503","article-title":"Hepatic injury associated with ketoconazole therapy","volume":"33","author":"Lewis James","year":"1984","journal-title":"Analysis of"},{"issue":"5","key":"10.1002\/14651858.CD004685.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/archpedi.153.5.483","article-title":"Asymptomatic dermatophyte carriers in the households of children with tinea capitis","volume":"153","author":"Pomeranz","year":"1999","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0063|cit63","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0065|cit65","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A (editors) GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations [updated October 2013] gdt.guidelinedevelopment.org\/central_prod\/_design\/client\/handbook\/handbook.html"},{"issue":"4","key":"10.1002\/14651858.CD004685.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jaad.2010.02.048","article-title":"Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis","volume":"64","author":"Tey","year":"2011","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD004685.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3314\/jjmm.46.61","article-title":"Current topics of tinea capitis in China","volume":"46","author":"Yu","year":"2005","journal-title":"Japanese Journal of Medical Mycology"},{"key":"10.1002\/14651858.CD004685.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-2008-1063858","article-title":"Update on azole antifungals","volume":"29","author":"Zonios","year":"2008","journal-title":"Seminars in Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004685.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004685.pub2","article-title":"Systemic antifungal therapy for tinea capitis in children","author":"Gonzalez","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004685.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T21:04:02Z","timestamp":1640120642000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004685.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Skin Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,12]]},"references-count":69,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004685.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,12]]}}}